Response Genetics, Inc (RGDXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 24, 2025, 8:00 PM EDT
Response Genetics Market Cap
Response Genetics has a market cap or net worth of $39.00 as of September 26, 2025. Its market cap has decreased by -99.97% in one year.
Market Cap
39.00
Enterprise Value
n/a
Revenue
16.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 6, 2007, Response Genetics's market cap has decreased from 71.67M to 39.00, a decrease of -100.00%. That is a compound annual growth rate of -55.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 39.00 | -99.97% |
| Dec 31, 2020 | 116.39K | 7.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Tian'an Technology Group | 705.53M |
| Elite Pharmaceuticals | 686.78M |
| Glass House Brands | 541.39M |
| Northwest Biotherapeutics | 375.87M |
| CytoDyn | 358.21M |
| American Oncology Network | 335.84M |
| Nika Pharmaceuticals | 299.34M |